A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [PDF]
L. Zhang +9 more
openalex +1 more source
A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity [PDF]
Patrick Jedlowski +3 more
openalex +1 more source
Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome [PDF]
Fernanda Cristofori +9 more
openalex +1 more source
Quantification of Central Substance P Receptor Occupancy by Aprepitant Using Small Animal Positron Emission Tomography [PDF]
Toshiki Endo +10 more
openalex +1 more source
Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. [PDF]
Wang Y +5 more
europepmc +1 more source
P35 Aprepitant in the prevention of cardiotoxic adverse effects of Doxorubicin in the paediatric population – a systematic literature investigation [PDF]
Martin Feickert, BB Burckhardt
openalex +1 more source
Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Children with Cancer [PDF]
Basch +31 more
core +1 more source
Targeting sirtuin 1/nuclear factor erythroid 2-related factor 2/tumor necrosis factor-α pathway to modulate hepatic ischemia reperfusion-induced injury. [PDF]
Kelleni MT +5 more
europepmc +1 more source

